Taiwanese Battery Manufacturer Selects Liberal for New U.S. Facility


TOPEKA – The Kansas Department of Commerce today announced Apogee Power, a Taiwan-based energy technology and advanced battery manufacturer, has selected Liberal as the location for its new U.S. manufacturing and assembly facility. The company will invest almost $16 million over the next three to five years and create 80 new jobs.

“In Kansas, we have a strong advanced battery ecosystem, talented workforce and central location that companies from around the world are eagerly looking to access,” Lieutenant Governor and Secretary of Commerce David Toland said. “Apogee’s decision to expand their work into Liberal highlights the strength of our rural communities and Kansas’ ability to compete on a global scale.”

The facility, located in Liberal’s industrial corridor, will support the assembly, testing and distribution of Apogee’s lithium iron phosphate (LFP) battery systems and related energy storage technologies for commercial, industrial and grid-scale applications across the United States. The company anticipates hiring 30 employees in the initial phase — with additional positions coming online as production ramps up.

Apogee is currently preparing the Liberal facility for production and expects to begin operations this summer. The facility represents Apogee’s first U.S. manufacturing presence and reflects their long-term commitment to serving customers from a centralized and cost-competitive location.

Apogee Power CEO Wen Lin, Apogee Energy CEO George Shen and other stakeholders were in Topeka recently to discuss the company’s investment and their desire to recruit additional suppliers from Taiwan to the Liberal area and other possible locations in Kansas. This followed a trade mission to Taiwan in September 2025, when Lieutenant Governor and Secretary of Commerce David Toland and other state and local officials visited Apogee Power’s headquarters in Taipei to meet their team and finalize the project details.

“Establishing a U.S. manufacturing footprint is a critical step in Apogee’s global growth strategy,” Apogee Power CEO Wen Lin said. “Liberal offers the infrastructure, workforce and community partnership we were looking for — along with a strong understanding of energy-intensive manufacturing. This location allows us to serve U.S. customers more efficiently while building a durable, long-term presence in the American market.”

Local leaders emphasized the collaborative approach that helped secure the project.

“We’re excited to welcome Apogee to Liberal,” Seward County Development Corporation Executive Director Eli Svaty said. “This investment builds on our region’s strengths in energy, logistics and advanced manufacturing. It also signals that global technology companies see value in smaller, execution-focused communities that can move quickly and deliver.”

Free Training

Source link

Volvo & Polestar: Moving EV Manufacturing to the US


Navigating challenging market conditions

The restructuring follows Polestar’s December 2025 announcement of a US$300m debt-to-equity conversion agreement with Geely Sweden Holdings, which maintains a controlling stake in Volvo Cars.

In March 2026, Polestar secured a US$300m investment from purchasers including Crédit Agricole CIB, Vida Finance S.A., Innovator Limited and Proximastar Holdings Company Limited as part of efforts to strengthen its financial position.

Manufacturing operations face significant headwinds as 100% tariffs on Chinese-made EVs impact the US market, with multiple companies adjusting or abandoning EV production plans.

“As market conditions remain challenging, we continue to take steps to make our organisation and operations more efficient,” Michael said when announcing Polestar’s operational results for the third quarter of 2025.

Free Training

Source link

Whirlpool Expands U.S. Manufacturing with New Ohio Plant


A photorealistic studio still-life image of a polished, chrome-plated washing machine or dryer drum, floating on a clean white background and dramatically lit from the side to highlight the reflective metallic surface.Whirlpool’s latest investment in U.S. manufacturing showcases the company’s commitment to producing premium, high-quality appliances domestically.Clyde Today

Whirlpool Corporation announced it will invest more than $60 million to establish a new manufacturing facility in Perrysburg, Ohio, creating between 100 and 150 jobs over the next two years. The new plant will be Whirlpool’s 11th U.S. factory and its sixth in Ohio, supporting nearby operations by producing appliance components and subassemblies for washers and dryers.

Why it matters

This expansion reflects Whirlpool’s continued confidence in American manufacturing and its commitment to producing high-quality, innovative products in the U.S. despite recent Wall Street concerns. It also underscores the company’s broader U.S. manufacturing strategy, with about 80% of major appliances sold domestically made in the United States.

The details

Whirlpool is repurposing an existing building in Perrysburg, formerly used for solar panel production, into a modern, technology-driven facility. Once complete, the new plant will blend automation with skilled labor to support nearby Ohio operations. This investment follows a larger $300 million expansion announced last fall to increase laundry production capacity in Clyde and Marion, Ohio, which is expected to create 400 to 600 additional jobs.

  • Whirlpool announced the new $60 million investment on April 11, 2026.
  • The new Perrysburg plant is expected to be operational and create 100-150 jobs over the next two years.

The players

Whirlpool Corporation

A major American home appliance manufacturer headquartered in Benton Harbor, Michigan, with a strong domestic manufacturing footprint, particularly in Ohio.

Marc Bitzer

The chairman and CEO of Whirlpool Corporation, who stated that this investment reflects the company’s confidence in American workers and its determination to produce high-quality, innovative products in the U.S.

Kristin Day

Whirlpool’s vice president of U.S. manufacturing, who said the new facility will blend automation with skilled labor to build the future of domestic production for the industry.

Got photos? Submit your photos here. ›

What they’re saying

“When there is a level playing field, our American workers can out-compete anyone in the world. This investment is proof of our confidence in that workforce and our determination to win by producing high-quality, innovative products in the U.S.”

— Marc Bitzer, Chairman and CEO, Whirlpool Corporation

“We are not just building appliances—we are building the future of domestic production for our industry. Our people remain the foundation of our success.”

— Kristin Day, Vice President of U.S. Manufacturing, Whirlpool Corporation

What’s next

Whirlpool’s new Perrysburg, Ohio plant is expected to move forward pending final approval of state and regional incentives, with a formal ribbon-cutting anticipated later this year.

The takeaway

This expansion demonstrates Whirlpool’s ongoing commitment to U.S. manufacturing, with about 80% of its major appliances sold domestically produced in the United States. The new Ohio plant is the latest in a series of recent investments that underscore the company’s confidence in American workers and its determination to maintain a strong domestic production footprint.

Free Training

Source link

Walmart’s AI Push Links Gemini App Experience With U.S. Manufacturing Shift


  • Walmart (NasdaqGS:WMT) is expanding its partnership with Google to integrate Gemini AI into the Walmart mobile app, aiming to support instant checkout and more personalized shopping.
  • The company is also backing Unspun’s AI driven textile production initiative in the U.S., targeting more domestic, tech enabled apparel manufacturing.
  • These moves come alongside Walmart’s broader shift toward platform style profit streams and more advanced, sustainable supply chains.

For investors watching Walmart (NasdaqGS:WMT), these AI and manufacturing moves sit on top of a share price of $126.787 and a 1 year return of 37.8%. Returns over 3 and 5 years are very large, with shares up 165.2% and 188.9% respectively. This underlines how closely the market is tracking Walmart’s repositioning beyond traditional retail margins.

The Gemini AI rollout and Unspun partnership point to Walmart tying digital engagement more tightly to how products are sourced and produced. For you as a shareholder or potential investor, the key question is how these projects influence customer loyalty, cost structure and the mix of higher margin, platform like revenue over time.

Stay updated on the most important news stories for Walmart by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Walmart.

NasdaqGS:WMT Earnings & Revenue Growth as at Apr 2026NasdaqGS:WMT Earnings & Revenue Growth as at Apr 2026

📰 Beyond the headline: 1 risk and 2 things going right for Walmart that every investor should see.

Quick Assessment

  • ⚖️ Price vs Analyst Target: At US$126.79, Walmart trades about 7% below the US$136.02 analyst target, which sits inside a wide US$62 to US$150 range.
  • ⚖️ Simply Wall St Valuation: The shares are described as trading close to estimated fair value, so this AI and manufacturing news comes against a roughly balanced valuation backdrop.
  • ✅ Recent Momentum: A 30 day return of 2.67% suggests the trend has been slightly positive into this announcement.

There is only one way to know the right time to buy, sell or hold Walmart: head to Simply Wall St’s
company report for the latest analysis of Walmart’s Fair Value.

Key Considerations

  • 📊 Gemini AI in the app and AI led U.S. textile production both speak to Walmart tying digital retail, data and supply chain control more tightly together.
  • 📊 Watch how engagement metrics, unit economics in fulfillment and any disclosure around AI driven productivity show up alongside the current 46.2x P/E.
  • ⚠️ One flagged risk is significant insider selling over the past 3 months, which some investors may weigh against these long term tech and manufacturing projects.

Dig Deeper

For the full picture including more risks and rewards, check out the
complete Walmart analysis. Alternatively, you can check out the
community page for Walmart to see how other investors believe this latest news will impact the company’s narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we’re here to simplify it.

Discover if Walmart might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Free Training

Source link

Acquisition Of U.S. Pharmaceutical Manufacturer Noble Pharma Expands Manufacturing Capabilities


Parnell, a veterinary pharmaceutical company, announced that it has acquired Noble Pharma, a U.S.-based pharmaceutical manufacturer, under a Securities Purchase Agreement dated November 26, 2025.

The acquisition adds an FDA- and DEA-accredited manufacturing facility to Parnell’s operations, strengthening its presence in the United States and supporting its long-term strategy to deliver high-quality products and reliable supply to customers and distribution partners. Noble Pharma’s capabilities enhance Parnell’s manufacturing footprint, improve supply continuity, and enable growth across its expanding product portfolio.

Noble Pharma, located in Menomonie, Wisconsin, produces a wide range of pharmaceutical formats, including suspensions, liquids, tablets, boluses, powders, gels, pastes, creams, and ointments.

Parnell said the transaction positions the company to scale production, accelerate innovation, and better serve its growing customer base across the U.S. market and internationally. The company currently develops, manufactures, and commercializes animal health solutions for companion and production animals in 10 countries.

KEY QUOTE:

“Completing this acquisition marks an important milestone for Parnell. Noble Pharma’s operational excellence and established U.S. manufacturing footprint perfectly complement our mission to provide consistent supply, superior quality, and exceptional service to our partners and customers.”

Brad McCarthy, Chief Executive Officer of Parnell

Free Training

Source link

Wood manufacturers call lumber dispute with U.S. broken


NORTH VANCOUVER — British Columbia’s wood manufacturing sector is again sounding the alarm about Canada’s softwood lumber dispute with the United States, calling it a “broken process.”

The response by the Independent Wood Processors Association comes after the U.S. Department of Commerce posted its preliminary tariff determination for the sector, estimated at just short of 25 per cent, lower than the current duty rate of more than 35 per cent.

The association says while it appears tariffs may be lowered, it cautions that there is still uncertainty on whether the finalized rate — expected in August — will actually represent a reduction of the current duty rate.

Executive director Brian Menzies also says that wood manufacturers are being unfairly punished, since companies do not hold timber tenures, harvest Crown timber or receive subsidies — and should not be included in the dispute.

The association also says an existing dispute-resolution process included in the Canada-United States-Mexico Agreement, also known as CUSMA, has not yielded “meaningful progress.”

It says the Canadian and U.S. governments need to “prioritize direct negotiations” instead of repeating the “cycle of endless litigation,” noting that consumers as well as workers and businesses on both sides of the border are being penalized with uncertainty and higher prices.

“After nearly a decade, it is obvious the current dispute mechanisms are not working,” Menzies said in a statement. “If legal channels cannot solve this, then political leaders need to step in and negotiate a real solution.”

“If the U.S. industry has real concerns, then let’s hear them … Enough hiding behind paperwork, bureaucracy, and endless administrative rulings.”

This report by The Canadian Press was first published April 10, 2026.

Free Training

Source link

Siemens is opening a railcar manufacturing plant in North Carolina


Siemens Mobility has officially inaugurated a railcar manufacturing plant in North Carolina, representing an investment of USD 220 million.

Government officials and leaders from the rail industry gathered today at Siemens Mobility’s rail manufacturing and service center in Lexington to mark a significant milestone in U.S. rail manufacturing. Construction of the facility is complete, production is underway, and the first locally built passenger railcars are scheduled for delivery in the summer of 2026.

The Lexington railcar factory is Siemens Mobility’s newest production facility in the United States and will play a key role in meeting the growing demand for passenger rail transportation nationwide. First announced in March 2023, the new Lexington site includes ten buildings on a 200-acre site.

The facility is dedicated to the production of Siemens Venture passenger railcars—among the most modern and innovative on the North American market—and will serve as a rail service hub on the East Coast, providing maintenance and major repair support for bogies, locomotives, and railcars, with the potential to service light rail vehicles in the future.

Once fully operational, this state-of-the-art facility will be the first in North America to offer both railcar and locomotive refurbishment and will utilize advanced digital technologies, including artificial intelligence, robotics, real-time analytics, and augmented reality, to streamline operations, improve decision-making, and set a new global standard for automated manufacturing.

Marking the beginning of a new generation of American rail transport, the facility was strategically designed with a dedicated rail bridge connected directly to the main line, enabling the efficient shipment of completed trains to customers on the East Coast and in other regions.

“Siemens Mobility’s investment in North Carolina manufacturing underscores the importance of rebuilding America’s transportation infrastructure right here at home. The impact of this facility will be felt for decades, supporting passenger rail services such as Amtrak on the Northeast Corridor and helping to deliver modern, reliable trains for travelers across the country,” said Steven Bradbury, Deputy Secretary of the U.S. Department of Transportation.

Hundreds of Employees at the North Carolina Railcar Plant

With over 375 employees already on board, the facility is on track to meet its goal of creating 500 new jobs by 2028, strengthening North Carolina’s economy and helping transform rail transportation across the country

Located in Davidson County, in the heart of the Piedmont Triad region, the city of Lexington offers access to a strong workforce and essential transportation networks. Partially supported by a Job Development Investment Grant from the state of North Carolina, estimated to add USD 1.6 billion to the state’s economy over 12 years, the Lexington site reinforces Siemens’ broader commitment to the U.S. industry.

Across all business sectors, Siemens employs approximately 45,000 people in the United States, works with 12,000 suppliers, and operates 24 manufacturing facilities nationwide, investing USD 700 million in U.S. manufacturing and over USD 20 billion in its technology infrastructure since 2007 to support the next era of digital and data-driven transformation.

Share on:
Facebooktwitterlinkedinmail

Free Training

Source link

Skyrover wants to replace DJI drones in America: Here’s its plan


skyrover drone us manufacturing warranty legit fcc

Skyrover, a relatively new but increasingly visible drone brand, is stepping into a tense and uncertain US market, and it’s doing so with a very clear message: we’re here to stay. Here’s what that means for American drone buyers right now.

A growing presence in the US drone market

Over the past year, Skyrover has quietly expanded its footprint in the United States, largely through mainstream retail channels like Best Buy and Amazon. That alone is notable since most emerging drone brands struggle to break into big-box distribution.

On the product side, Skyrover has been targeting entry-level and mid-range consumers, especially those who want to shoot vertical videos and social media content. Drone enthusiasts have pointed out similarities between Skyrover’s flight systems and technology used within the broader DJI ecosystem, suggesting the drone may benefit from engineering concepts derived from the tech giant’s platforms. But at the end of the day, Skyrover wants to distinguish itself by offering DJI-style capabilities without DJI-style prices.

The $289 Skyrover S1, for instance, features a 1/2-inch Sony sensor capable of capturing 48-megapixel photos and 4K video at 60 frames per second. Another standout feature is forward obstacle avoidance, something rarely seen in drones under $300. Skyrover X1, on the other hand, promises a 1/1.32-inch CMOS sensor, 360° obstacle avoidance, true vertical shooting, AI tracking, and extended transmission range for only $499.

Advertisement – scroll for more content

The elephant in the room: Regulation

Skyrover’s recent public statement directly addresses a growing concern among US drone buyers: Will foreign-made drones remain viable in the long term?

That concern isn’t unfounded. Policymakers and regulators, including the Federal Communications Commission, have been tightening scrutiny on foreign technology, particularly devices that rely on radio communications and data transmission. The FCC plays a key role here because any drone sold in the US must comply with its equipment authorization rules. These regulations ensure that devices:

  • Use approved radio frequencies
  • Avoid harmful interference
  • Meet safety and communication standards

More recently, the FCC has also been exploring restrictions tied to national security concerns. The FCC has already added foreign-made drones and key components to its “Covered List” following national security determinations. While some devices were later removed, most foreign-produced UAS and critical components still face restrictions when it comes to entering the US market.

Skyrover’s response: Reassurance and a roadmap

Skyrover is tackling those concerns head-on. In its statement to US customers, the company emphasizes that all its drones sold domestically are fully FCC-compliant and designed to meet current regulatory standards. That’s the baseline, but the more interesting part is what comes next. The company has laid out a five-year roadmap that reads as both a commitment and a strategic signal.

Short term (within one year):

  • Maintain FCC compliance across all products
  • Expand retail availability and local inventory
  • Improve US-based customer support, including replacement-first service

That last point stands out. Instead of traditional repair workflows, Skyrover is leaning into replacement-based support, which could significantly reduce downtime for users.

Mid-term (2-3 years):

  • Build a stronger US team
  • Deepen partnerships with retailers and service providers
  • Improve after-sales infrastructure

Long-term (up to five years):

  • Explore US-based manufacturing
  • Localize parts of its supply chain
  • Continue adapting to evolving regulations

For American consumers, the biggest fear isn’t just buying a drone, it’s buying one that might lose support, updates, or legality down the line. Skyrover is clearly trying to get ahead of that narrative. By emphasizing regulatory compliance, local support infrastructure, and potential US manufacturing, the company is positioning itself as a stable, long-term player rather than a short-lived import brand.

Of course, execution will matter more than promises. Building a US supply chain and maintaining regulatory alignment, especially in a fast-changing policy environment, is no small task. But Skyrover’s message reflects a broader shift happening across the drone industry. As geopolitical tensions and regulatory scrutiny increase, foreign drone makers are being forced to localize operations, increase transparency, and invest in long-term US strategies.

For now, Skyrover’s approach is simple: reassure customers, stay compliant, and build trust over time.

More: GoPro’s new camera might be its biggest comeback move


Add DroneDJ as a preferred source on Google
Add DroneDJ as a preferred source on Google

FTC: We use income earning auto affiliate links. More.

Free Training

Source link

Shionogi sets sights on US antibiotic plant with $119M from BARDA


Japan’s Shionogi is joining the spate of drugmakers to announce manufacturing commitments in the U.S. since last year, albeit under slightly different circumstances than many of its peers.

The Osaka-headquartered company on Wednesday unveiled a new contract through the U.S.’ Biomedical Advanced Research and Development Authority (BARDA) to bolster the domestic supply of Fetroja (cefiderocol) and potentially expand the antibiotic’s purview to tackle “high biothreat pathogens” like plague and melioidosis. 

Fetroja won its first U.S. green light back in 2019 as a treatment for complicated urinary tract infections, following that up a year later with a second FDA nod in hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP and VABP). 

In its April 8 announcement, Shionogi noted that the deal positions Fetroja as a “critical countermeasure” against those difficult-to-treat infections, plus other biological threats to U.S. national health security. 

BARDA, part of HHS’ Administration for Strategic Preparedness and Response (ASPR), has funded the contract with an initial $119 million, although “multiyear options” could ultimately net Shionogi up to $482 million if exercised, the company said. 

With that cash, Shionogi says it will establish a dedicated U.S. manufacturing site for Fetroja, with the funding also expected to help support the med’s procurement. The company did not elaborate on expected capacity or a potential location for the upcoming production plant. 

At the same time, the drugmaker will hunker down to advance development of Fetroja to treat infections caused by “high priority biothreat pathogens” like melioidosis (Burkholderia pseudomallei) and plague (Yersinia pestis), plus Shionogi will seek an FDA expansion to treat HABP and VABP in pediatric patients. 

“Shionogi is proud of our ongoing commitment to combating antimicrobial resistance, as shown by the continued investment in Fetroja since its introduction in 2020, expanding our portfolio with the acquisition of Qpex Biopharma, Inc. in 2023, and further investing in Qpex to establish a new research facility dedicated to advancing antimicrobial research and development in 2025,” Nathan McCutcheon, president and CEO of Shionogi Inc., Shionogi’s U.S. subsidiary, said in a statement. 

“This contract complements our existing work with the U.S. government and enables us to advance our ongoing expansion efforts in the U.S. at greater pace and scale,” McCutcheon added.

Shionogi notes that it has discovered and brought six novel antibiotics to market over a 70-year span. 

The Fetroja contract falls under BARDA’s Project BioShield, which aims to accelerate R&D, procurement and availability of medical countermeasures meant to tackle chemical, biological, radiological and nuclear agents. 

Apart from the antibiotic focus on display in its Shionogi tie-up, BARDA has laid out several major prophylactic supply pacts in recent years. 

Beyond deals for U.S. supplies of COVID-19 vaccines—plus therapeutics and diagnostics—during the pandemic, BARDA has helped shore up American stockpiles of vaccines for smallpox and mpox through Bavarian Nordic, and the agency has engaged with GSK, Sanofi and CSL to shore up inventories of bird flu shots, too. 

More recently, Cidara Therapeutics snagged a BARDA award worth up to $339 million in October to support domestic manufacturing for its experimental non-vaccine flu preventive, CD388, and help establish an “initial commercial supply chain” for the asset. Since then, the biotech has been bought out by Merck for $9.2 billion.

Free Training

Source link

Reshoring: The Domestic Manufacturing Shift



Reshoring(Photo: Adobe Stock / Chopang Studio)

By Howard Riell
From the March/April 2026 Issue

The trend among so many American companies of reshoring—bringing manufacturing and more back to the United States—is proving to be seismic. Under President Donald Trump, many major companies have announced large investments in U.S. production expansions during 2025 and now in 2026, signaling a shift back toward domestic production in strategic sectors.  

GlobalFoundries, for one, has said it is investing $16 billion to reshore chip manufacturing. Stellantis, the owner of Jeep, Ram, Dodge, unveiled a $13 billion U.S. manufacturing investment. And Johnson & Johnson plans to spend $55 billion to build facilities in the United States, partly responding to trade and supply chain pressures.  

Federal announcements in 2025 point to more than $200 billion in multi-year U.S. investment commitments, led by major life sciences companies. In addition to Johnson & Johnson, other significant announcements came from AstraZeneca ($50 billion), Bristol Myers Squibb ($40 billion), GSK ($30 billion), and Eli Lilly and Company ($27 billion). While not always labeled as reshoring, these projects represent significant domestic capacity expansion aligned with federal priorities. 

Activity has been especially concentrated in four sectors: pharmaceuticals, semiconductors, advanced manufacturing, and energy and data infrastructure—industries increasingly tied to national security and supply chain resilience.

On the employment side, reshoring and foreign direct investment continued to generate substantial, if moderating, gains. Approximately 244,000 U.S. jobs were announced in 2024, down slightly from the 2023 peak. While investment momentum remained strong in 2025, job creation is scaling more gradually as projects move from announcement to operation.

These investment announcements are significant, and jobs numbers are substantial compared with historical levels. Companies have cited numerous reasons for bringing manufacturing or business operations back home after they had previously been moved overseas. These include supply chain reliability, tariffs or trade policy changes, rising overseas labor costs, automation reducing labor-cost advantages, national security concerns, and Made in USA branding benefits. 

American Machinist is reporting that industry surveys and analyses suggest that reshoring will continue to grow if the U.S. significantly expands its skilled manufacturing workforce. In fact, if American companies can fill more skilled jobs, some studies estimate that a meaningful share of currently off-shored production—as much as 30% of OEM-offshored products—could come back. 

Reshoring: A Broader View

“Reshoring to the U.S. has experienced steady, moderate growth over the past 10 years, and I expect that to continue,” predicts Rosemary Coates, Executive Director of the Reshoring Institute in Los Gatos, CA, which provides expert guidance on global manufacturing strategy.

“The bigger story is that now companies are considering the global landscape and choosing multiple places to source and manufacture,” Coates continues. “This new way of thinking mitigates the risks of regionalized disasters and geopolitics and allows companies to take advantage of low-cost labor. It is also an opportunity to develop new markets and customers and manufacture products close to where they are sold, thereby reducing carbon footprint and developing sustainability programs. What I see is not just reshoring, nearshoring, or friendshoring, but global supply chain management that is rethinking its world.”

She adds, “What we are seeing from our Reshoring Institute clients is a movement away from China and into other Asian countries and Mexico. Mexico has become a very attractive destination because of its low-cost labor and rapidly developing manufacturing capabilities.”

 Still, geopolitics and the Trump Administration’s changing tariff policy has made selecting alternate global manufacturing locations a challenge. Says Coates, “Companies are unsure of what tariffs might be imposed, causing additional costs on importing raw materials, parts, and finished products. While long-term, this may result in reshoring, in the short term, it increases costs.”

Long before a site selection begins, Coates explains, the Reshoring Institute encourages companies to analyze their product cost structures so that they have a clear picture of the percentage of production that is related to materials and what percentage is related to labor. She points out: “If labor is greater than 50% of the overall cost, then a low-cost labor area is very important.”

Reshoring(Image: Adobe Stock / Foxeel)

Foreign-Trade Zones: Place To Land 

Jeffrey J. Tafel, CAE, President of the National Association of Foreign-Trade Zones (NAFTZ), emphasizes that foreign-trade zones are “a proven competitiveness tool for reshoring, helping manufacturers/importers/exporters lower total landed costs, mitigate tariff exposure, defer duties and improve cash flow—often enough to shift the ROI in favor of U.S. investment.” 

NAFTZ, an association of public and private members, is the collective voice of the U.S. Foreign-Trade Zones Program. Association members increasingly use foreign-trade zones not just for duty savings, Tafel explains, “but as resilience platforms that enable flexible sourcing, domestic assembly, and faster response to customers. For nearshoring in Mexico and Canada, U.S. FTZs complement USMCA (The United States-Mexico-Canada Agreement) by supporting more integrated North American supply chains—allowing firms to optimize cross-border flows while keeping higher-value operations anchored in the U.S.” 

Cost volatility, supply chain risk, geopolitics and customer proximity are all converging to reshape sourcing strategies. 

“NAFTZ consistently hears that unpredictable tariffs, shipping disruptions and geopolitical exposure have made ‘lowest-cost country’ models far riskier,” says Tafel, “while U.S. FTZ benefits and state and local incentives materially narrow the cost gap for U.S. locations. Being closer to customers improves speed and customization, making reshoring and nearshoring a strategic risk management decision, not just a cost play.” 

Supply chain resilience has helped change the way manufacturers evaluate sites today compared to five years ago. Says Tafel, “Site selection has shifted from a primary focus on labor and tax incentives to a broader resilience lens that prioritizes logistics access, supplier redundancy, regulatory readiness and the ability to pivot sourcing quickly.” 

From NAFTZ’s perspective, companies are integrating trade compliance and tariff strategy earlier in site selection—recognizing that operational flexibility and trade tools like U.S. FTZs are now core competitive advantages, not back-office considerations. 

Many firms are positively surprised by how much total landed cost can be reduced through U.S. FTZ benefits, incentives, and logistics efficiencies when viewed holistically, Tafel points out. “Similarly, companies often underestimate the true cost of offshore complexity—inventory carrying costs, compliance burdens, disruption risk and lost revenue from slow response times—which reshoring can materially reduce.” 

Case In Point: John Deere, GE Appliances

Other companies are likewise looking forward and underscoring that there is no place like home. 

In keeping with its self-described “strong tradition of building America,” Moline, IL-based John Deere has rolled out plans to open two new U.S.-based facilities: a state-of-the-art distribution center near Hebron, IN, and a cutting-edge excavator factory in Kernersville, NC. Both are set to open within the next year.  

The Kernersville campus reshores manufacturing and production from Japan. The company already operates over 60 facilities across more than 16 states. 

“Our investment in these new facilities underscores John Deere’s dedication to strengthening the backbone of American industry and supporting local economies,” said John May, Chairman and Chief Executive Officer of the manufacturer of agricultural, construction, and forestry machinery, turf care equipment and diesel engines. “We believe in building America, and these projects represent our intent to continue driving innovation and job creation in the United States.”

“These investments further demonstrate our commitment to invest $20 billion in U.S. manufacturing over the next 10 years,” May said. 

Another example: last summer, GE Appliances, a Haier company, said it would invest more than $3 billion over the next five years in its U.S. operations, workforce, and communities. The first phase of investments will begin at GE Appliances plants in Kentucky, Alabama, Georgia, Tennessee, and South Carolina. Upon completion of this plan, GE Appliances will have invested $6.5 billion across its U.S. manufacturing plants and nationwide distribution network since 2016. 

Workforce “Foundational”

What lies ahead? Workforce availability and skills are “foundational” to reshoring decisions, NAFTZ’s Tafel believes, even as expectations evolve toward technical roles supported by automation.  

And Coates observes, “While workers may be available, they often do not have the skills to operate in a sophisticated and automated manufacturing environment. I often say we have a skills shortage in the U.S., not a labor shortage. There needs to be more emphasis on education—particularly engineering—and the development of community college programs and apprenticeships.”

With more than 4,000 new U.S. jobs added since 2016, and more than 1,000 new jobs anticipated from its five-year plan, GE Appliances places employees as central to its growth strategy.

“Infrastructure and tools matter, but they are not enough,” said Bill Good, GE Appliances’ Vice President of Supply Chain. “America’s manufacturing renaissance will be built by people. That’s why we’re partnering with universities, technical schools, and high schools to develop the next generation of manufacturing leaders. We’re not just bringing jobs back—we’re bringing purpose, pride, and possibility back to American industry.” 

For its part, NAFTZ sees firms pairing FTZ-enabled cost savings with deeper investments in training partnerships and workforce pipelines to make reshoring viable, increasingly prioritizing regions that can demonstrate sustained talent development and adaptability. 

Tafel maintains that reshoring’s momentum will depend on policy stability, predictable trade and tariff regimes, workforce readiness, and sustained infrastructure investment.  

“NAFTZ believes momentum will continue if companies can plan with confidence—knowing U.S. FTZs, incentives, and trade programs will remain reliable tools to offset cost pressures,” he concludes. “Increased policy volatility or talent constraints would risk slowing the pace of investment.”

Snapshots

Snapshot: Puerto Rico

Puerto Rico offers a compelling reshoring value proposition as a U.S. jurisdiction with global reach. Companies benefit from full access to the U.S. market, strong legal and intellectual property protections, and eligibility for federal programs, while operating within a cost-competitive structure. The island’s long-standing manufacturing base, particularly in biosciences, medical devices, and advanced manufacturing, is supported by a highly skilled, bilingual workforce and mature supplier networks. 

Puerto Rico’s strategic location provides efficient access to North America, Latin America, and Europe, helping companies reduce transit times and strengthen supply chain resilience. Incentives under Act 60 and a streamlined business-establishment process further enhance competitiveness for high-value operations, particularly those seeking long-term operational stability within the U.S. 

Recent expansions reinforce this momentum. Amgen, Eli Lilly, CooperVision, Terumo, Millicent Pharma, and others continue to invest and expand on the island —underscoring Puerto Rico’s role as a proven reshoring destination within the United States.

Snapshot: U.S. Virgin Islands

As companies rethink global supply chains, the U.S. Virgin Islands (USVI) emerges as one of the most strategically advantaged U.S. jurisdictions for reshoring and nearshoring. As a U.S. territory outside the U.S. customs zone and exempt from the Jones Act, the USVI allows foreign-flag vessels to move goods directly between the Territory and global markets, reducing shipping constraints and expanding routing options.

On St. Croix, the South Shore Trade Zone features commercial land for development, available warehouse space, and direct access to deep-water ports accommodating drafts of up to 30 feet. An international airport in the zone, with warehouse facilities in close proximity, further enhances multimodal connectivity, enabling efficient movement of goods from port to port and air to sea.

Coupled with competitive tax incentives and a stable U.S. legal framework, the USVI stands out as a resilient, flexible, and globally connected destination for manufacturers, logistics providers, and distributors positioning for long-term growth in the Americas and beyond.

Check out all the latest economic development, corporate relocation, corporate expansion and site selection news related to reshoring and nearshoring.

Free Training

Source link